FierceBiotech

FireceBiotech Chutes & Ladders

Jul 9, 2021 9:30am

“Immix Bio, focused on tissue-specific therapeutics for oncology and inflammation, chose Gabriel Morris as its chief financial officer and board member.”

Original Article Link

Tags:

Comments are closed